Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Vascular calcification.

Catherine M Shanahan1

  • 1Department of Medicine, University of Cambridge, Cambridge, UK. cs131@mole.bio.cam.ac.uk

Current Opinion in Nephrology and Hypertension
|June 3, 2005
PubMed
Summary
This summary is machine-generated.

Vascular calcification in end-stage renal disease is driven by high phosphate and calcium levels, leading to vascular smooth muscle cell damage and conversion. Further research is needed to fully understand and manage this process.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Matrix-associated extracellular vesicles modulate human smooth muscle cell adhesion and directionality by presenting collagen VI.

eLife·2025
Same author

Leducq-funded network: calcification-omics, molecular elucidation, and therapeutics (COMET).

European heart journal·2025
Same author

Mineral Stress Drives Loss of Heterochromatin: An Early Harbinger of Vascular Inflammaging and Calcification.

Circulation research·2025
Same author

ECM Modifications Driven by Age and Metabolic Stress Directly Promote Vascular Smooth Muscle Cell Osteogenic Processes.

Arteriosclerosis, thrombosis, and vascular biology·2025
Same author

Liver kinase B1: a master regulator of vascular smooth muscle cell fate and vascular metabolic homeostasis?

Cardiovascular research·2024
Same author

Phylloquinone improves endothelial function, inhibits cellular senescence, and vascular inflammation.

GeroScience·2024
Same journal

Primary prevention of chronic kidney disease in type 2 diabetes mellitus with sodium-glucose cotransporter 2 inhibitors.

Current opinion in nephrology and hypertension·2026
Same journal

Financial and policy challenges of delivering kidney replacement therapies in resource-limited settings.

Current opinion in nephrology and hypertension·2026
Same journal

The role of kir4.1/Kir5.1 in mediating the effect of angiotensin-II on Na-Cl-cotransporter.

Current opinion in nephrology and hypertension·2026
Same journal

Role of the calcium-sensing receptor in regulating calcium transport in the thick ascending limb.

Current opinion in nephrology and hypertension·2026
Same journal

Social determinants of chronic kidney disease: from association to clinical and population action.

Current opinion in nephrology and hypertension·2026
Same journal

Advancing science and care in CKD-MBD: the layered path to legacy.

Current opinion in nephrology and hypertension·2026
See all related articles

Area of Science:

  • Nephrology
  • Cardiovascular Biology
  • Cell Biology

Background:

  • End-stage renal disease (ESRD) is associated with high cardiovascular mortality, partly due to progressive vascular calcification.
  • Vascular calcification in ESRD patients on dialysis contributes significantly to adverse cardiovascular outcomes.

Purpose of the Study:

  • To review recent cell biological and animal studies on the mechanisms and regulators of vascular smooth muscle cell calcification in ESRD.
  • To elucidate the cellular processes underlying vascular calcification in the context of kidney disease.

Main Methods:

  • Review of recent cell biological and animal studies.
  • Analysis of clinical data linking circulating factors to vascular calcification.
  • Investigation of mechanisms of vascular smooth muscle cell calcification in response to insults.

Related Experiment Videos

Main Results:

  • High circulating phosphate and calcium levels predict vascular calcification.
  • Vascular smooth muscle cell damage and vesicle release create a pro-calcification environment.
  • Osteogenic conversion of vascular smooth muscle cells and impaired inhibitory pathways contribute to calcification.
  • Factors like fetuin-A and the uremic milieu influence vascular calcification; links to bone metabolism are established.

Conclusions:

  • Understanding of vascular smooth muscle cell calcification mechanisms in ESRD remains incomplete.
  • Integrated studies combining epidemiology, in-vitro, animal, and clinical research are required.
  • Further research should focus on modifying risk factors to improve vessel wall health in ESRD patients.